Oncology Management Podcast Series with Bill McGivney

Welcome to the Oncology Management Podcast Series. 

Joining us today is Bill McGivney, Principal, McGivney Global Advisory LLC & former CEO, National Comprehensive Cancer Network. Below you will find a teaser from Bill's podcast session, click here to listen to the complete podcast and to download the transcript.

How and to what extent do various stakeholders bring value to the treatment of patients with cancer?

Bill: Well, I think that’s something that we really need to look at closer because there are a lot of discussions, obviously, about the level of healthcare expenditures and the increase and rate of rise and expenditures of care to treat patients with cancer.

First of all, you look at providers and clearly their expertise, their acumen and their understanding is really about providing what the optimal treatment recommendations are for patients. Carrying out that treatment plan brings a lot of value to the system.

And then you look at the manufacturers, the biopharma companies, the medical device companies and they bring innovative products to the market that address the many, many needs and unmet needs that still exist for the many different types of cancer specifically. And that’s critical. They bring value to patients directly.

Then, you start to get down into other areas of the healthcare system that are more management operations oriented and you look at managed-care companies. They bring value in the sense that they help to organize the system. They pay the claims and the develop networks of clinicians to work with patients specifically.

But, really, what I think we need to do is, as we expend resources to bring care ultimately to patients with cancer, we really need to take a closer look at, again, which components, which stakeholders bring actual value to the treatment of patients.

Download the rest of the Podcast here.

To hear more from Bill, please join us at IIR’s Annual Oncology Management Summit, July 21-23 in Philadelphia, PA.

To save 15% off your registration rate, use the code: XP1914BLOG

Register Now!

Summit for Oncology Management Podcast Series with Dr. Ronan Kelly of John Hopkins

Summit for Oncology Management Podcast Series

Below is a teaser from our podcast series with Dr. Ronan Kelly...

Director of Gastroesophageal Cancer Therapeutics Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Medical Director of Global Oncology, John Hopkins International

Download the full podcast & transcript here.

To begin, the Institute of Medicine has declared that cancer care in the US is a system in crisis. Do you agree? 

Dr. Kelly: The word “crisis”, I think, may not be the best word to use. I certainly think that major changes are needed. If we, as a cancer community, do not take ownership of some of the problems that we will talk about today, then I think others will make the tough decisions for us.
What we have learned, especially in the last couple of years, is that costs will not constrain themselves and that we really are reaching a tipping point where we need to take definitive and direct action. Often, some uncomfortable actions will be required to get on back on path.

Some of the trends that are amplifying the crisis – as pointed out by the Institute of Medicine – is that we do have an aging population of, thankfully, more and more survivors. But, what we are seeing is a 30% increase in cancer survivors by 2020 as a result of many of the significant scientific treatment advances that we’ve been able to achieve in the last couple of years. But we are also seeing that the incidence of cancer is expected to go up approximately 45% by 2030. So, because of these changing or increasing patient survivors and increasing cancer numbers, we are seeing that the cost of cancer care is really, really going up. In the US we are expecting between 2010 and 2020 that there will be a 39% increase in the cost of cancer care up to $173 billion and some experts are even saying that this may be conservative estimate.

So, I think we certainly need to make changes. The current system that we have right now is not sustainable. So, some direct and often uncomfortable actions will need to be done in order to get us back on track. And to ensure that we continue to treat future generations with better and better treatments. So, some decisions are needed right now. I would agree that the system needs to be altered and, in some cases, needs to be dramatically fixed.

To hear more from Dr. Kelly, please join us July 21-23 in Philadelphia, PA for IIR's Summit for Oncology Management. 

To receive 15% off the standard registration rate, use the code: XP1914BLOG

Save 15% today, register now.

Download the Brochure | Oncology Management Summit 2014

At IIR’s Oncology Management Summit taking place July 21-23 in Philadelphia, you will walk away with solutions to the most critical issues within the cancer care value chain: excessive costs, access to affordable care, incorporating new technology, and meeting new value and quality standards for patient-centered care. Pioneers in oncology share never-before-heard research and perspectives to drive your programs and patient care strategies forward.

2014 Event highlights include:

• NEW! Delve into the role of specialty pharmacy in oncology during the pre-conference summit
• NEW! Sessions on the impact of Big Data as it transforms cancer care management
• More than 40 dedicated sessions with a focus on economic and cost issues, quality and value of patient access & care, and data and technology driven strategies

To learn more, download our brochure.

Register with code XP1914BLOG and save 15% off of our standard rate. Questions about the event? Email our group manager, Kate Devery (KDevery@IIRUSA.com). For more information, visit our website.

We look forward to seeing you this July!

Cheers,
The Oncology Management Team

Opt-in for updates
Oncology Twitter
Oncology LinkedIn

Session Spotlight: Screenings, Biomarkers & Diagnostic Testing to Manage Outcomes and Costs

Advances in our understanding of the genetic mutations and alterations and resultant expression are leading to the identification of more and more biomarkers to help direct patient management. Biomarker development and applications are being seen in early detection, prognosis, toxicity profiling, predictive, effective monitoring, follow up, etc.

IIR’s Collaborative Summit for Oncology brings together a multi-stakeholder view of the current state of biomarker use and how the use of these applications will lead to less toxic care. They will also discuss insights into what you can expect to see in the next 3-5 years to increase positive outcomes and manage costs of oncology.

SESSION SPOTLIGHT:  The Use of Screenings, Biomarkers & Diagnostic Testing to Increase Positive Outcomes and Manage Cost of Oncology

Moderator: Paul Howard, Director and Senior Fellow Center for Medical Progress, Manhattan Institute for Policy Research

Panelists:

• William T. McGivney, PhD, Former NCCN CEO, McGivney Global Advisors
• Oscar Puig, Biomarker Lead in Oncology, Translational Clinical Research Center, Roche
• Maurie Markman, MD, Senior Vice President, Clinical Affairs, Cancer Treatment Centers of America

To learn more, download our brochure.

As a reader of the healthcare insights blog, you can use priority code XP1814BLOG to receive 15% off of the standard rate to register. If you have any questions or need any further information, feel free to email kdevery@iirusa.com or visit the webpage.

We look forward to seeing you in June!

Best,
Oncology Management Team

Visit the Oncology Management Webpage
Follow us on Twitter

Oncology Management Industry Outlook

IIR’s collaborative Summit for Oncology Management will deliver dedicated sessions on the outlook of oncology management to prepare you for the evolving reimbursement landscape and the effect on you and your business, including:

Industry Trends: What’s Happening in Healthcare? Jayson Slotnik, Partner, Health Policy Strategies, LLC

What’s the Impact of Healthcare Reform on Cancer Care?

Moderator:
Elan Rubinstein, PharmD, MPH, EB Rubinstein Associates

Panelists: 
• Michael Kolodziej, MD, FACP, Medical Director, Oncology Strategy,Office of the Chief Medical Officer, Aetna
• William T. McGivney, PhD, Former NCCN CEO, McGivney Global Advisors
• Jack Whelan, Patient Advocate & Member, Personalized Medicine Coalition
 
The Use of Screenings, Biomarkers & Diagnostic Testing to Increase Positive Outcomes and Manage Cost of Oncology

Moderator:
Paul Howard, Director and Senior Fellow Center for Medical Progress, Manhattan Institute for Policy Research

Panelists:
• William T. McGivney, PhD, Former NCCN CEO, McGivney Global Advisors
• Oscar Puig, Biomarker Lead in Oncology, Translational Clinical Research Center, Roche
• Maurie Markman, MD, Senior Vice President, Clinical Affairs, Cancer Treatment Centers of America

To learn more, download our brochure.

As a readerr of the healthcare insights blog, you can use priority code XP1814BLOG to receive 15% off of the standard rate to register. If you have any questions or need any further information, feel free to email kdevery@iirusa.com or visit the webpage.

We look forward to seeing you in June!

Best,
Oncology Management Team

Visit the Oncology Management Webpage
Follow us on Twitter

Download IIR's Collaborative Summit for Oncology Management Podcast Featuring: Ira Klein

In this Executive Podcast, Mr. Klein shares his thoughts on the impact of healthcare reform on cancer care and the greatest changes and challenges managed care companies will see in the coming years. He'll also talk about Aetna's Compassionate Care Program and how this program is actively engaging Oncologists with patients early on. As the leader of the Oncology Solutions Team at Aetna, he'll bring his expertise to the all-new IIR Oncology Management Summit as Chairman and Keynote Panelist on the Real-World View on the Cancer Care System.

Download the Podcast!

IIR is introducing the Collaborative Summit for Oncology Management during a time when cancer care is undergoing a period of rapid transformation. As you strive to meet the emerging value mandate, this summit delivers multi-stakeholder perspectives on innovative managed care strategies to effectively manage costs while improving quality and effectiveness of cancer care. Influence the future of oncology management with these key event take-aways:

• Multi-stakeholder view of the oncology management marketplace

• Lessons learned from payment and healthcare delivery reform pilot programs

• Meet and collaborate with oncology leaders spearheading industry change

To learn more, download our brochure.

As a reader of the Oncology Management Professionals blog, you can use priority code XP1814BLOG to receive 15% off of the standard rate to register. If you have any questions or need any further information, feel free to email kdevery@iirusa.com or visit the webpage.

We look forward to seeing you in June!

Best,
Oncology Management Team

Visit the Oncology Management Webpage
Follow us on Twitter

Key Players Convene to Improve Quality and Cost of Cancer Care

IIR’s Collaborative Summit for Oncology Management brings together perspectives from a diverse range of companies — public and private payers, providers, health systems, patient groups, pharmaceutical companies, PBMs, and specialty pharmacies. Together, you will address key topics to uncover innovative managed care strategies that effectively manage your rising costs while gaining new ways to improve the quality and effectiveness of cancer care.

The in-depth speaker line-up at the Oncology Management Summit is comprised of experts, leaders, and executives including:

• Lee Newcomer, SVP, Oncology, Genetics and Women’s Health, UnitedHealthcare
• Ira Klein, Chief of Staff, Office of the Chief Medical Officer, Aetna
• Barbara Walters, MD, Executive Medical Director, Dartmouth – Hitchcock
• Ted Okon, Executive Director, Community Oncology Alliance (COA)
• Jan Berger, MD, Chief Medical Officer, Silverlink Communications
• Karen Fields, MD, Medical Director, Strategic Alliances, Moffitt Cancer Center
• Gwen Darien, Director, The Pathways Project
• Bruce J. Gould, MD, Medical Director, Northwest Georgia Oncology Centers
• Michael Kolodziej, MD, FACP, Medical Director, Oncology Strategy, Office of the Chief Medical Officer, Aetna
• Elan Rubinstein, PharmD, MPH, EB Rubinstein Associates
• William T. McGivney, PhD, Former NCCN CEO, McGivney Global Advisors
• Jack Whelan, Patient Advocate & Member, Personalized Medicine Coalition

To learn more, download our brochure.

As a reader of this blog, you can use priority code XP1814BLOG to receive 15% off of the standard rate to register. If you have any questions or need any further information, feel free to email kdevery@iirusa.com or visit the webpage.

We look forward to seeing you in June!

Best,
Oncology Management Team

Visit the Oncology Management Webpage
Follow us on Twitter: https://twitter.com/healthcarebiz

Will increasing the quality of palliative care help decrease the number of hospital visits?

Could optimizing the quality of cancer care and cost at home help reduce both the number of hospital visits, and increase survival rates? According to the Journal of the National Cancer Institute, there have been no studies to show that increased spending also increases patient survival rates.

Advanced cancer spending varied by up to 41 percent between high- and low-spending regions. The Midwest and West contained the majority of low-spending regions, while high-spending regions were located in central New Jersey, Southern California and Louisiana, Medscape Medical News reported.

Although researchers have found that increased spending relating to cancer care also correlates to longer hospital stays they must consider a significant amount of that number could be from chemotherapy costs. Is making palliative care more accessible the solution?

Want to learn more about managing palliative care? At IIR’s Collaborative Summit for Oncology Management, we'll discuss new ways to manage palliative and end-of-life care to control cost and improve patient outcomes. To learn more, download our brochure.

As a reader of this blog you receive 15% off the standard rate when your register using code XP1814BLOG. We hope to see you June 17-18 in Chicago!

Announcing IIR’s Oncology Management Summit & Brochure Available for Download

IIR is introducing the all-new Collaborative Summit for Oncology Management during a time when cancer care is undergoing a period of rapid transformation. As you strive to meet the emerging value mandate, this summit delivers multi-stakeholder perspectives on innovative managed care strategies to effectively manage costs while improving quality and effectiveness of cancer care.

Influence the future of oncology management with these key event take-aways:

● Multi-stakeholder view of the oncology management marketplace

● Lessons learned from payment and healthcare delivery reform pilot programs

● Meet and collaborate with oncology leaders spearheading industry change

Who Should Attend? 

This summit is specially designed for managed care health plan executives working in oncology in:

● Medical management
● Pharmacy
● Operations
● Quality management
● Disease management

The summit is also of interest to Pharmaceutical and Medical Device executives as well as PBMs, specialty pharmacies, hospitals and health systems, and provider groups.

To learn more, download our brochure.

As a reader of the Oncology Care Professionals blog, you can use priority code XP1814BLOG to receive 15% off of the standard rate to register. If you have any questions or need any further information, feel free to email kdevery@iirusa.com or visit the webpage.

We look forward to seeing you in June!

Best,
Oncology Management Team

Visit the Oncology Management Webpage
Follow us on Twitter